Skip to main content
Annovis Bio, Inc. logo

Annovis Bio, Inc. — Investor Relations & Filings

Ticker · ANVS ISIN · US03615A1088 LEI · 549300IFBVI51FN3NJ32 US Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2022-04-18 Proxy Solicitation & In…
Country US United States of America
Listing US ANVS

About Annovis Bio, Inc.

https://www.annovisbio.com/

Annovis Bio, Inc. is a clinical-stage drug platform company that develops therapies for neurodegenerative diseases. The company's primary focus is on conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD). Its lead product candidate, buntanetap, is a translational inhibitor designed to halt the death of nerve cells by targeting the synthesis of multiple neurotoxic proteins. The company's therapeutic approach aims to restore nerve cell function, with the goal of improving cognitive and motor abilities in patients suffering from neurodegeneration.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or additional materials related to a shareholder meeting. It includes information about the annual meeting of stockholders, voting instructions, election of directors, and ratification of the independent auditor. It does not contain the full proxy statement itself but rather additional materials or a notice regarding the proxy materials. The document is about soliciting shareholder votes and providing information for the annual meeting, which fits the definition of Proxy Solicitation & Information Statement (PSI). The document length is 6810 characters, which is consistent with a detailed proxy solicitation document rather than a brief announcement or a full annual report. Therefore, the correct classification is PSI.
2022-04-18 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-18 English
10-K
Annual Report FY 2021
2022-03-02 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-01-18 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-01-18 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-01-05 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.